欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6792/001
药品名称Abirateron Cipla
活性成分
    • abiraterone acetate 250.0 mg
剂型Tablet
上市许可持有人Cipla Europe De Keyserlei 58-60 Box 19 2018 Antwerpen Belgium
参考成员国 - 产品名称Germany (DE)
Abirateron Cipla 250 mg Tabletten
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • France (FR)
    • Italy (IT)
    • Romania (RO)
      Abiraterone Cipla 250 mg comprimate
    • Poland (PL)
      Abiraterone Cipla
    • Austria (AT)
许可日期2022/06/09
最近更新日期2022/06/21
药物ATC编码
    • L02BX03 abiraterone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase